Navigation Links
Getting under the shell of the turtle genome
Date:3/28/2013

The genome of the western painted turtle (Chrysemys picta bellii) one of the most widespread, abundant and well-studied turtles in the world, is published this week in Genome Biology. The data show that, like turtles themselves, the rate of genome evolution is extremely slow; turtle genomes evolve at a rate that is about a third that of the human genome and a fifth that of the python, the fastest lineage analyzed.

As a group, turtles are long-lived, can withstand low temperatures including freezing solid, can survive for long periods with no oxygen, and their sex is usually determined by the temperature at which their eggs develop rather than genetically. The painted turtle is most anoxia-tolerant vertebrate and can survive up to four months under water depending on the temperature. Turtles and tortoises are also the most endangered major vertebrate group on earth, with half of all species listed as endangered. This is the first turtle, and only the second non-avian reptile genome to be sequenced, and the analysis reveals some interesting insights about these bizarre features and adaptations, many of which are only known in turtles.

The western painted turtle is a freshwater species, and the most widespread turtle native to North America. Bradley Shaffer and colleagues place the western painted turtle genome into a comparative evolutionary context, showing that turtles are more closely related to birds and crocodilians than to any other vertebrates. They also find 19 genes in the brain and 23 in the heart whose expression is increased in low oxygen conditions including one whose expression changes nearly 130 fold. Further experiments on turtle hatchlings indicated that common microRNA was involved in freeze tolerance adaptation.

This work consistently indicates that common vertebrate regulatory networks, some of which have analogs in human diseases, are often involved in the western painted turtle achieving its extr
'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Page: 1 2

Related biology news :

1. Why getting healthy can seem worse than getting sick
2. Light weights are just as good for building muscle, getting stronger, researchers find
3. Scripps Florida scientists identify neurotranmitters that lead to forgetting
4. University of Tennessee anthropologists find American heads are getting larger
5. Carbon is key for getting algae to pump out more oil
6. Getting to the root -- unearthing the plant-microbe quid pro quo
7. For young birds, getting stressed out can be a good thing
8. Getting (drugs) under your skin
9. Texas cotton getting a genetic tune-up
10. Overweight pregnant women not getting proper weight-gain advice
11. Cheating -- and getting away with it
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... July 23, 2015 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... 2015 was $4.5 million, a decrease of 33% compared to ... in the second quarter of 2015 was $0.3 million, or ... $0.04 per diluted share, in the same period a year ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... Irvine, Calif., Nov. 21, 2011 UC Irvine and Italian ... of anandamide a natural, marijuana-like chemical in the body ... Louise Turner Arnold Chair in the Neurosciences, the team identified ... sites within the cell where enzymes break it down. They ...
... Log and lumber exports from Washington, Oregon, northern California, and ... the total exports of 2010 according to the U.S. Forest ... shipments to China are the main driver of the hike ... Xiaoping Zhou, a research economist with the station. "The log ...
... with 43 of the companies honored by Thomson Reuters ... a record year of expansion, fueled by businesses, increased ... "The organizations that continue to surge ahead ... innovate," said Andy Zynga, Chief Executive Officer of NineSigma, ...
Cached Biology News:UCI-led team finds new way to boost potency of marijuana-like chemical in body 2West coast log, lumber exports in first 9 months of 2011 surpass 2010 totals 2West coast log, lumber exports in first 9 months of 2011 surpass 2010 totals 3Surging Demand for Innovation Services Leads to Record Expansion for NineSigma 2Surging Demand for Innovation Services Leads to Record Expansion for NineSigma 3
(Date:7/27/2015)... According to the new Market Research ... Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), by Geography ... , Asia-Pacific , Rest of the World) ... market was valued at $247.7 million in 2014, which is ... a CAGR of 18.2% between 2014 and 2019. ...
(Date:7/27/2015)... July 27, 2015 Junto Health, a company ... information and develop new technology solutions, today announced the ... (SPG), a leader in health care policy consulting. Working ... in a collaborative innovation process while, at the same ... in public policy, health care finance and the delivery ...
(Date:7/27/2015)... ... , ... Visual Assay was named as a finalist for the 53rd Annual ... services of the past year. More than 70 judges selected the finalists, including ... announced at the 2015 R&D 100 Awards Dinner on November 13 at Caesars Palace ...
(Date:7/25/2015)... , ... July 25, 2015 , ... ... its refractometer series. It precisely checks and adjusts the surface temperature of the ... , In the pharmaceutical industry, data traceability and documentation are key requirements. It ...
Breaking Biology Technology:Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2It’s T-Time for Refractometers: On-site Temperature Check Now Available 2
... Mersana, a cancer,therapeutics company, announced today that Timothy ... Officer., "We are thrilled that Tim is now ... President and CEO at Mersana. "His extensive leadership in,oncology ... an,ideal match for Mersana. In addition to the important ...
... CuraGen Corporation,(Nasdaq: CRGN ) announced today that ... present at the BIO CEO & Investor Conference,on Wednesday, ... Access to a live webcast of the presentation ... the webcast will be accessible,beginning one hour after the ...
... at 2008 BIO CEO & Investor conference at the Waldorf-Astoria ... on Tuesday, February 12 at 1:15 PM (Eastern), NEW ... A. Bianco, M.D., President and CEO of Cell,Therapeutics, Inc. (CTI) ... Company,s sales and marketing strategy intended to grow Zevalin(R),(Ibritumomab Tiuxetan) ...
Cached Biology Technology:Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 3Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 4Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 5
ID clarifier: Without ethidium bromide...
... / 3T3 cells were cultured in DMEM with ... phase of growth. In order to keep ... fixed in acetone-methanol. The cells are arrayed ... with each wells surface specifically treated to enhance ...
... Application: Acridine orange has been used as ... agarose and polyacrylamide gels. Acridine orange at ... purified DNA in gels with a sensitivity ... also been used extensively for cell staining ...
... vector can be induced prior to DNA ... the stability of single-copy BACs with the ... cloning vectors. The kits provide the linearized ... size screening system) necessary to create a ...
Biology Products: